Nasal continuous positive airway pressure (nCPAP) treatment for obstructive sleep apnea, road traffic accidents and driving simulator performance: A meta-analysis

Sleep Medicine Reviews

Volumn 15, Issue 5, 2011, Pages 301-310

  Antonopoulos, Constantine N ^a   Sergentanis, Theodoros N ^a   Daskalopoulou, Styliani S ^b   Petridou, Eleni Th ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

Author keywords

Driving simulator; Meta analysis; Nasal continuous positive airway pressure; NCPAP; Obstructive sleep apnea; Road traffic accidents

Indexed keywords

ADULT; ATTRIBUTABLE RISK; CONFIDENCE INTERVAL; DRIVING ABILITY; HUMAN; INCIDENCE; MALE; META ANALYSIS (TOPIC); OUTCOME ASSESSMENT; PERFORMANCE; POSITIVE END EXPIRATORY PRESSURE; REGRESSION ANALYSIS; REVIEW; RISK; SLEEP APNEA SYNDROME; STANDARDIZED INCIDENCE RATIO; TRAFFIC; TRAFFIC ACCIDENT;

ACCIDENTS, TRAFFIC; AUTOMOBILE DRIVING; CONTINUOUS POSITIVE AIRWAY PRESSURE; FEMALE; HUMANS; MALE; MIDDLE AGED; REGRESSION ANALYSIS; SLEEP APNEA, OBSTRUCTIVE;

EID: 80051580694     PISSN: 10870792     EISSN: 15322955     Source Type: Journal    
DOI: 10.1016/j.smrv.2010.10.002     Document Type: Review

References (48)

1. Epstein L.J., Kristo D., Strollo P.J., Friedman N., Malhotra A., Patil S.P., et al. Clinical guideline for the evaluation, management and long-term care of obstructive sleep apnea in adults. J Clin Sleep Med 15 Jun 2009, 5(3):263-276.
2. Punjabi N.M. The epidemiology of adult obstructive sleep apnea. Proc Am Thorac Soc 15 Feb 2008, 5(2):136-143.
3. Jennum P., Riha R.L. Epidemiology of sleep apnoea/hypopnoea syndrome and sleep-disordered breathing. Eur Respir J Apr 2009, 33(4):907-914.
4. Tregear S., Reston J., Schoelles K., Phillips B. Obstructive sleep apnea and risk of motor vehicle crash: systematic review and meta-analysis. J Clin Sleep Med 15 Dec 2009, 5(6):573-581.
5. Young T., Peppard P.E., Gottlieb D.J. Epidemiology of obstructive sleep apnea: a population health perspective. Am J Respir Crit Care Med 1 May 2002, 165(9):1217-1239.
6. McDaid C., Griffin S., Weatherly H., Duree K., van der Burgt M., van Hout S., et al. Continuous positive airway pressure devices for the treatment of obstructive sleep apnoea-hypopnoea syndrome: a systematic review and economic analysis. Health Technol Assess 2009 Jan, 13(4). iii-iv, xi-xiv, 1-119, 143-274.
7. Gay P., Weaver T., Loube D., Iber C. Evaluation of positive airway pressure treatment for sleep related breathing disorders in adults. Sleep 1 Mar 2006, 29(3):381-401.
8. Abad V.C., Guilleminault C. Treatment options for obstructive sleep apnea. Curr Treat Options Neurol Sep 2009, 11(5):358-367.
9. Liberati A., Altman D.G., Tetzlaff J., Mulrow C., Gotzsche P.C., Ioannidis J.P., et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. J Clin Epidemiol Oct 2009, 62(10):e1-e34.
10. Sullivan C.E., Issa F.G., Berthon-Jones M., Eves L. Reversal of obstructive sleep apnoea by continuous positive airway pressure applied through the nares. Lancet 18 Apr 1981, 1(8225):862-865.
11. Harbour R., Miller J. A new system for grading recommendations in evidence based guidelines. BMJ 11 Aug 2001, 323(7308):334-336.
12. Johns M.W. A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep Dec 1991, 14(6):540-545.
13. George C.F. Reduction in motor vehicle collisions following treatment of sleep apnoea with nasal CPAP. Thorax Jul 2001, 56(7):508-512.
14. Krieger J., Meslier N., Lebrun T., Levy P., Phillip-Joet F., Sailly J.C., et al. Accidents in obstructive sleep apnea patients treated with nasal continuous positive airway pressure: a prospective study. The working group ANTADIR, Paris and CRESGE, Lille, France. Association Nationale de Traitement a Domicile des Insuffisants Respiratoires. Chest Dec 1997, 112(6):1561-1566.
15. Cuijpers P., van Straten A., Smit F., Mihalopoulos C., Beekman A. Preventing the onset of depressive disorders: a meta-analytic review of psychological interventions. Am J Psychiatry Oct 2008, 165(10):1272-1280.
16. Hozo S.P., Djulbegovic B., Hozo I. Estimating the mean and variance from the median, range, and the size of a sample. BMC Med Res Methodol 2005, 5(1):13.
17. Higgins J., Green S. Cochrane handbook for systematic reviews of interventions v5.0.2 2009, Available from. http://www.cochrane-handbook.org/.
18. Duval S., Tweedie R. Trim and fill: a simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics 2000 Jun, 56(2):455-463.
19. Orwin R. A fail-safe N for effect size in meta-analysis. Journal of educational and behavioral statistics 1983, 8(2):157-159.
20. Orth M., Leidag M., Kotterba S., Widdig W., de Zeeuw J., Walther J.W., et al. Estimation of accident risk in obstructive sleep apnea syndrome (OSAS) by driving simulation. Pneumologie Jan 2002, 56(1):13-18.
21. Orth M., Herting A., Duchna H.W., Walther J.W., de Zeeuw J., Bauer T.T., et al. Driving simulator performance in patients with obstructive sleep apnea syndrome: what consequences for driving capability?. Dtsch Med Wochenschr 11 Nov 2005, 130(45):2555-2560.
22. Hack M.A., Choi S.J., Vijayapalan P., Davies R.J., Stradling J.R. Comparison of the effects of sleep deprivation, alcohol and obstructive sleep apnoea (OSA) on simulated steering performance. Respir Med Jul 2001, 95(7):594-601.
23. Scharf M.B., Stover R., McDannold M.D., Spinner O., Berkowitz D.V., Conrad C. Outcome evaluation of long-term nasal continuous positive airway pressure therapy in obstructive sleep apnea. Am J Ther Nov 1999, 6(6):293-297.
24. Cassel W., Ploch T., Becker C., Dugnus D., Peter J.H., von Wichert P. Risk of traffic accidents in patients with sleep-disordered breathing: reduction with nasal CPAP. Eur Respir J Dec 1996, 9(12):2606-2611.
25. Engleman H.M., Asgari-Jirhandeh N., McLeod A.L., Ramsay C.F., Deary I.J., Douglas N.J. Self-reported use of CPAP and benefits of CPAP therapy: a patient survey. Chest Jun 1996, 109(6):1470-1476.
26. Findley L., Smith C., Hooper J., Dineen M., Suratt P.M. Treatment with nasal CPAP decreases automobile accidents in patients with sleep apnea. Am J Respir Crit Care Med Mar 2000, 161(3 Pt 1):857-859.
27. Horstmann S., Hess C.W., Bassetti C., Gugger M., Mathis J. Sleepiness-related accidents in sleep apnea patients. Sleep 1 May 2000, 23(3):383-389.
28. Minemura H., Akashiba T., Yamamoto H., Suzuki R., Itoh D., Kurashina K., et al. Traffic accidents in obstructive sleep apnea patients and effect of nasal CPAP treatment. Nihon Kyobu Shikkan Gakkai Zasshi Sep 1993, 31(9):1103-1108.
29. Suratt P., Findley L. Effect of nasal CPAP treatment on automobile driving simulator performance and on self-reported automobile accidents in subjects with sleep apnea (Abst). Am Rev Respir Dis 1992, 145:A169.
30. Yamamoto H., Akashiba T., Kosaka N., Ito D., Horie T. Long-term effects nasal continuous positive airway pressure on daytime sleepiness, mood and traffic accidents in patients with obstructive sleep apnoea. Respir Med Jan 2000, 94(1):87-90.
31. Findley L.J., Fabrizio M.J., Knight H., Norcross B.B., LaForte A.J., Suratt P.M. Driving simulator performance in patients with sleep apnea. Am Rev Respir Dis 1989, 140(2):529-530.
32. George C.F., Boudreau A.C., Smiley A. Effects of nasal CPAP on simulated driving performance in patients with obstructive sleep apnoea. Thorax Jul 1997, 52(7):648-653.
33. Hack M., Davies R.J., Mullins R., Choi S.J., Ramdassingh-Dow S., Jenkinson C., et al. Randomised prospective parallel trial of therapeutic versus subtherapeutic nasal continuous positive airway pressure on simulated steering performance in patients with obstructive sleep apnoea. Thorax Mar 2000, 55(3):224-231.
34. Orth M., Duchna H.W., Leidag M., Widdig W., Rasche K., Bauer T.T., et al. Driving simulator and neuropsychological [corrected] testing in OSAS before and under CPAP therapy. Eur Respir J Nov 2005, 26(5):898-903.
35. Turkington P.M., Sircar M., Saralaya D., Elliott M.W. Time course of changes in driving simulator performance with and without treatment in patients with sleep apnoea hypopnoea syndrome. Thorax Jan 2004, 59(1):56-59.
36. Barbe F., Sunyer J., de la Pena A., Pericas J., Mayoralas L.R., Anto J.M., et al. Effect of continuous positive airway pressure on the risk of road accidents in sleep apnea patients. Respiration 2007, 74(1):44-49.
37. Furukawa T.A. From effect size into number needed to treat. Lancet 15 May 1999, 353(9165):1680.
38. McAlister F.A. The " number needed to treat" turns 20-and continues to be used and misused. CMAJ 9 Sep 2008, 179(6):549-553.
39. He J., Whelton P.K., Vu B., Klag M.J. Aspirin and risk of hemorrhagic stroke: a meta-analysis of randomized controlled trials. JAMA 9 Dec 1998, 280(22):1930-1935.
40. Ribeiro M.L., Seres A.I., Carneiro A.M., Stur M., Zourdani A., Caillon P., et al. Effect of calcium dobesilate on progression of early diabetic retinopathy: a randomised double-blind study. Graefes Arch Clin Exp Ophthalmol Dec 2006, 244(12):1591-1600.
41. Giles T.L., Lasserson T.J., Smith B.H., White J., Wright J., Cates C.J. Continuous positive airways pressure for obstructive sleep apnoea in adults. Cochrane Database Syst Rev 2006, 3. CD001106.
42. Howard M.E., Desai A.V., Grunstein R.R., Hukins C., Armstrong J.G., Joffe D., et al. Sleepiness, sleep-disordered breathing, and accident risk factors in commercial vehicle drivers. Am J Respir Crit Care Med 1 Nov 2004, 170(9):1014-1021.
43. Pack A.I., Maislin G., Staley B., Pack F.M., Rogers W.C., George C.F., et al. Impaired performance in commercial drivers: role of sleep apnea and short sleep duration. Am J Respir Crit Care Med 15 Aug 2006, 174(4):446-454.
44. Ayas N.T., FitzGerald J.M., Fleetham J.A., White D.P., Schulzer M., Ryan C.F., et al. Cost-effectiveness of continuous positive airway pressure therapy for moderate to severe obstructive sleep apnea/hypopnea. Arch Intern Med 8 May 2006, 166(9):977-984.
45. Tan M.C., Ayas N.T., Mulgrew A., Cortes L., FitzGerald J.M., Fleetham J.A., et al. Cost-effectiveness of continuous positive airway pressure therapy in patients with obstructive sleep apnea-hypopnea in British Columbia. Can Respir J Apr 2008, 15(3):159-165.
46. Sassani A., Findley L.J., Kryger M., Goldlust E., George C., Davidson T.M. Reducing motor-vehicle collisions, costs, and fatalities by treating obstructive sleep apnea syndrome. Sleep 1 May 2004, 27(3):453-458.
47. Tousignant P., Cosio M.G., Levy R.D., Groome P.A. Quality adjusted life years added by treatment of obstructive sleep apnea. Sleep Feb 1994, 17(1):52-60.
48. Petridou E., Dessypris N., Frangakis C.E., Belechri M., Mavrou A., Trichopoulos D. Estimating the population burden of injuries: a comparison of household surveys and emergency department surveillance. Epidemiology Jul 2004, 15(4):428-432.